Searchable abstracts of presentations at key conferences in endocrinology

ea0007p257 | Clinical case reports | BES2004

Transformation of a micro-prolactinoma to a macro-prolactinoma during pregnancy without symptoms or signs of pituitary enlargement: two case reports

Dixon A , Rangan S , Singh B

Transformation of a micro-prolactinoma to a macro-prolactinoma during pregnancy is rare. During treatment of micro-prolactinoma it is conventional to stop dopamine agonist treatment prior to or at conception and only re-image the pituitary if the patient presents with symptoms or signs of pituitary enlargement. We present two cases of micro-prolactinoma transforming to macro-prolactinoma during pregnancy. Neither case presented with symptoms or signs of pituitary enlargement. ...

ea0029p961 | Female Reproduction | ICEECE2012

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case–control study

Singh S. , Akhtar N. , Ahmad J.

Objective: An interaction between adiponectin, steroid synthesis or action and measures of insulin resistance (IR) have been reported in the pathogenesis of polycystic ovary syndrome (PCOS). The present study was done to determine plasma adiponectin concentration (PAC) in women with and without PCOS and to assess its correlation to the hormonal and metabolic parameters including measures of IR. The effect of metformin for 6 months in PCOS was also evaluated.<p class="abste...